Pfizer (United States)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2006

  1. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial

    Arthritis and Rheumatism, Vol. 54, Núm. 4, pp. 1063-1074

  2. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: The TEMPO trial

    Annals of the Rheumatic Diseases, Vol. 65, Núm. 3, pp. 328-334